FcRn‐targeting and ROS‐responsive Fedratinib‐incorporated nanoparticles alleviate asthma by inducing eosinophil apoptosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

FcRn‐targeting and ROS‐responsive Fedratinib‐incorporated nanoparticles alleviate asthma by inducing eosinophil apoptosis

Published:2022-11-20 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Sun Weimin¹²^ORCID,Song Shijie¹,Li Guangmeng¹,Zhou Linghui¹,Xie Junmou¹,Guo Yuhe¹,Zeng Jun¹,Zhang Junyan¹,Li Linmei¹,He Ying¹,Yan Jie¹^ORCID,Shuai Xintao¹³⁴,Tao Ailin¹^ORCID

Affiliation:

1. The Second Affiliated Hospital, The State Key Laboratory of Respiratory Disease, Guangdong Provincial Key Laboratory of Allergy & Clinical Immunology Guangzhou Medical University Guangzhou China

2. Department of Laboratory Medicine The Seventh Affiliated Hospital of Southern Medical University Foshan China

3. Department of Gastrointestinal Surgery The Third Affiliated Hospital of Sun Yat‐sen University Guangzhou China

4. PCFM Lab of Ministry of Education, School of Materials Science and Engineering Sun Yat‐sen University Guangzhou China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15575

Reference6 articles.

1. Type 2 immunity in the skin and lungs

2. GM-CSF, IL-3, and IL-5 Family of Cytokines: Regulators of Inflammation

3. Eosinophil Survival and Apoptosis in Health and Disease

4. Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis

5. Nanoformulated ABT-199 to effectively target Bcl-2 at mitochondrial membrane alleviates airway inflammation by inducing apoptosis

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology’s frontier in combatting infectious and inflammatory diseases: prevention and treatment;Signal Transduction and Targeted Therapy;2024-02-21

2. Resolving the etiology and treatments of allergic diseases;Allergy;2023-05-31

3. Eosinophils from A to Z;Allergy;2023-05-07

4. Progress in nanoparticle-based regulation of immune cells;Medical Review;2023-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3